These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26467273)

  • 81. Biological responses of dog prostate and adjacent structures after meso-tetra-(m-hydroxyphenyl) chlorin and aluminum disulfonated phthalocyanine based photodynamic therapy.
    Chang SC; Chern IF; Hsu YH
    Proc Natl Sci Counc Repub China B; 1999 Oct; 23(4):158-66. PubMed ID: 10518316
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer.
    Solban N; Selbo PK; Sinha AK; Chang SK; Hasan T
    Cancer Res; 2006 Jun; 66(11):5633-40. PubMed ID: 16740700
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.
    Momma T; Hamblin MR; Wu HC; Hasan T
    Cancer Res; 1998 Dec; 58(23):5425-31. PubMed ID: 9850075
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland.
    Huang Z; Haider MA; Kraft S; Chen Q; Blanc D; Wilson BC; Hetzel FW
    Lasers Surg Med; 2006 Aug; 38(7):672-81. PubMed ID: 16799982
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study.
    Rapozzi V; Varchi G; Della Pietra E; Ferroni C; Xodo LE
    Invest New Drugs; 2017 Feb; 35(1):115-123. PubMed ID: 27726093
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT).
    Abels C
    Photochem Photobiol Sci; 2004 Aug; 3(8):765-71. PubMed ID: 15295633
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Vascular targeted photochemotherapy using padoporfin and padeliporfin as a method of the focal treatment of localised prostate cancer - clinician's insight.
    Bugaj AM
    World J Methodol; 2016 Mar; 6(1):65-76. PubMed ID: 27019798
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Clinical evaluation of experimentally induced choroidal neovascularizations in pigmented rabbits by subretinal injection of lipid hydroperoxide and consecutive preliminary photodynamic treatment with Tookad.
    Framme C; Sachs HG; Kobuch K; Flucke B; Birngruber R
    Ophthalmologica; 2008; 222(4):254-64. PubMed ID: 18525218
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
    You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
    Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Laser dosimetry studies in the prostate.
    Chen Q; Hetzel FW
    J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer.
    Lebdai S; Gigoux M; Alvim R; Somma A; Nagar K; Azzouzi AR; Cussenot O; Merghoub T; Wolchok JD; Scherz A; Kim K; Coleman J
    Oncoimmunology; 2019; 8(6):e1581528. PubMed ID: 31069149
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Photodynamic therapy on prostate cancer cells involve mitochondria membrane proteins.
    Xu DD; Leong MML; Wong FL; Lam HM; Hoeven R
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101933. PubMed ID: 32717455
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Re: Padeliporfin Vascular-Targeted Photodynamic Therapy versus Active Surveillance in Men with Low-Risk Prostate Cancer (CLIN1001 PCM301): An Open-Label, Phase 3, Randomised Controlled Trial.
    Taneja SS
    J Urol; 2017 Aug; 198(2):255-257. PubMed ID: 29370650
    [No Abstract]   [Full Text] [Related]  

  • 94. Prostate cancer: Enhancing VTP.
    Thoma C
    Nat Rev Urol; 2018 Apr; 15(4):204. PubMed ID: 29532804
    [No Abstract]   [Full Text] [Related]  

  • 95. Prostate cancer: Light, camera, action - photodynamic therapy for low-risk disease.
    Stone L
    Nat Rev Urol; 2017 Mar; 14(3):134. PubMed ID: 28072400
    [No Abstract]   [Full Text] [Related]  

  • 96. Vascular targeted photodynamic therapy: A review of the efforts towards molecular targeting of tumor vasculature.
    Mashayekhi V; Hoog CO'; Oliveira S
    J Porphyr Phthalocyanines; 2019 Dec; 23(11-12):1229-1240. PubMed ID: 33568892
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    Chen D; Yuan W; Park HC; Li X
    Biomed Opt Express; 2020 Aug; 11(8):4316-4325. PubMed ID: 32923045
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Final Results of a Phase I/II Multicenter Trial of WST11 Vascular Targeted Photodynamic Therapy for Hemi-Ablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Performed in the United States.
    Taneja SS; Bennett J; Coleman J; Grubb R; Andriole G; Reiter RE; Marks L; Azzouzi AR; Emberton M
    J Urol; 2016 Oct; 196(4):1096-104. PubMed ID: 27291652
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Vascular targeted photodynamic therapy with TOOKAD® Soluble (WST11) in localized prostate cancer: efficiency of automatic pre-treatment planning.
    Betrouni N; Boukris S; Benzaghou F
    Lasers Med Sci; 2017 Aug; 32(6):1301-1307. PubMed ID: 28569345
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Focal Laser Ablation and Photodynamic Vascular Therapy with soluble TOOKAD® in the treatment of low risk prostate cancer].
    Domínguez-Escrig JL; Casanova Ramón-Borja J
    Arch Esp Urol; 2016 Jul; 69(6):327-36. PubMed ID: 27416636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.